miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability by hypoxia
{{output}}
Central nervous system (CNS)-related diseases are difficult to treat as most therapeutic agents they cannot reach the brain tissue, mainly due to the blood-brain barrier (BBB), arguably the tightest barrier between the human body and cerebral parenchyma, which... ...